Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.

Abstract

Endometrial bleeding and alteration in blood coagulation, fibrinolysis, ovarian function and endometrial morphology were studied in twelve normally menstruating women who received the injectable contraceptive norethisterone enanthate (NET-EN) 200mg at 60-day intervals. Levels of clotting factor VII declined significantly during episodes of irregular bleeding compared to those during both normal pretreatment menstruation and the bleeding-free period during treatment. Antithrombin III and fibrinolytic activity, expressed by euglobulin lysis time, showed no marked change. The average level of progesterone during the bleeding-free period was slightly but significantly lower than that during the bleeding period. There were no significant alterations in the mean levels of estradiol and the ratio of estradiol to progesterone. The endometrial biopsies showed considerable individual variation and seem to be independent of the effects of NET-EN on ovarian function.

• Authors: Y X Meng, P Virutamasen
• Journal: Contraception (Contraception) Vol. 44 Issue 1 Pg. 73-82 (Jul 1991) ISSN: 0010-7824 [Print] United States
• PMID: 1893702 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Contraceptive Agents, Female
• Gonadal Steroid Hormones
• norethindrone enanthate
• Norethindrone

Topics

• Adult
• Blood Coagulation (drug effects)
• Contraceptive Agents, Female (pharmacology)
• Endometrium (drug effects)
• Female
• Gonadal Steroid Hormones (blood)
• Humans
• Menstrual Cycle (drug effects)
• Norethindrone (analogs & derivatives, pharmacology)
• Thailand